Provided By GlobeNewswire
Last update: Mar 12, 2025
HOLLISTON, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the fourth quarter and full year ended December 31, 2024.
Read more at globenewswire.com0.489
+0.01 (+2.71%)
Find more stocks in the Stock Screener